| Sources | Names Used |
|---|---|
| CTRPv2 | PRL-3 inhibitor I |
| PharmacoGx | PRL-3 Inhibitor I |
| Database | Identifier |
|---|---|
| Smiles: | Brc1ccc(OCc2ccccc2Br)c(/C=C3/SC(=S)NC3=O)c1 |
| Pubchem: | 11983303 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAD51L3-RFFL | CTRPv2 | pan-cancer | AAC | -0.068 | 0.09 |
| mRNA | TUBA8 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | CBX8 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.09 |
| mRNA | GINM1 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.09 |
| mRNA | HSD17B12 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | ZBBX | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | BRD7 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | EIF3CL | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | ATP5SL | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | IRX2 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.09 |
